Indian drugmakers are also concerned about a shift in India’s position on IPR, which they say is being keenly watched by many developing co...

The move will drastically reduce prices of key drugs, but at the same time, jeopardise the plans of multinational drug companies.

A discussion paper put up for consultation by DIPP suggests that the drugs industry may be taken off the list of sectors where FDI is allow...